DOI: 10.1055/s-00000025

Hormone and Metabolic Research

Referenz

Anastasilakis AD, Papapoulos SE, Polyzos SA. et al.
Zoledronate for the prevention of bone loss in women discontinuing denosumab treatment. A prospective 2-year clinical trial.

J Bone Miner Res 2019;
34: 2220-2228

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: